Larkin SJ - Search Results

1

A Noninvasive Comparison Study between Human Gliomas with IDH1 and IDH2 Mutations by MR Spectroscopy.

Shen X, Voets NL, Larkin SJ, de Pennington N, Plaha P, Stacey R, McCullagh JSO, Schofield CJ, Clare S, Jezzard P, Cadoux-Hudson T, Ansorge O, Emir UE. Shen X, et al. Among authors: larkin sj. Metabolites. 2019 Feb 20;9(2):35. doi: 10.3390/metabo9020035. Metabolites. 2019. PMID: 30791611 Free PMC article.

2

Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.

Emir UE, Larkin SJ, de Pennington N, Voets N, Plaha P, Stacey R, Al-Qahtani K, Mccullagh J, Schofield CJ, Clare S, Jezzard P, Cadoux-Hudson T, Ansorge O. Emir UE, et al. Among authors: larkin sj. Cancer Res. 2016 Jan 1;76(1):43-9. doi: 10.1158/0008-5472.CAN-15-0934. Epub 2015 Dec 15. Cancer Res. 2016. PMID: 26669865 Free PMC article.

3

Improved localisation for 2-hydroxyglutarate detection at 3T using long-TE semi-LASER.

Berrington A, Voets NL, Plaha P, Larkin SJ, Mccullagh J, Stacey R, Yildirim M, Schofield CJ, Jezzard P, Cadoux-Hudson T, Ansorge O, Emir UE. Berrington A, et al. Among authors: larkin sj. Tomography. 2016 Jun;2(2):94-105. doi: 10.18383/j.tom.2016.00139. Tomography. 2016. PMID: 27547821 Free PMC article.

4

A comparison of 2-hydroxyglutarate detection at 3 and 7 T with long-TE semi-LASER.

Berrington A, Voets NL, Larkin SJ, de Pennington N, Mccullagh J, Stacey R, Schofield CJ, Jezzard P, Clare S, Cadoux-Hudson T, Plaha P, Ansorge O, Emir UE. Berrington A, et al. Among authors: larkin sj. NMR Biomed. 2018 Mar;31(3). doi: 10.1002/nbm.3886. Epub 2018 Jan 5. NMR Biomed. 2018. PMID: 29315915

5

Pathology and pathogenesis of craniopharyngiomas.

Larkin SJ, Ansorge O. Larkin SJ, et al. Pituitary. 2013 Mar;16(1):9-17. doi: 10.1007/s11102-012-0418-4. Pituitary. 2013. PMID: 22886701 Review.

6

Rathke's cleft cyst.

Larkin S, Karavitaki N, Ansorge O. Larkin S, et al. Handb Clin Neurol. 2014;124:255-69. doi: 10.1016/B978-0-444-59602-4.00017-4. Handb Clin Neurol. 2014. PMID: 25248592 Review.

7

BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma.

Larkin SJ, Preda V, Karavitaki N, Grossman A, Ansorge O. Larkin SJ, et al. Acta Neuropathol. 2014;127(6):927-9. doi: 10.1007/s00401-014-1270-6. Epub 2014 Apr 9. Acta Neuropathol. 2014. PMID: 24715106 Free PMC article. No abstract available.

8

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas.

Larkin S, Reddy R, Karavitaki N, Cudlip S, Wass J, Ansorge O. Larkin S, et al. Eur J Endocrinol. 2013 Mar 15;168(4):491-9. doi: 10.1530/EJE-12-0864. Print 2013 Apr. Eur J Endocrinol. 2013. PMID: 23288882

9

Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.

Larkin SJ, Ferraù F, Karavitaki N, Hernández-Ramírez LC, Ansorge O, Grossman AB, Korbonits M. Larkin SJ, et al. Eur J Endocrinol. 2014 Dec;171(6):705-10. doi: 10.1530/EJE-14-0545. Epub 2014 Sep 15. Eur J Endocrinol. 2014. PMID: 25225481

10

The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis.

Preda V, Larkin SJ, Karavitaki N, Ansorge O, Grossman AB. Preda V, et al. Among authors: larkin sj. Endocr Pathol. 2015 Mar;26(1):1-8. doi: 10.1007/s12022-014-9341-8. Endocr Pathol. 2015. PMID: 25355426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters